Melanoma/Skin Cancer

Top Story

CIRT: Methotrexate fails to prevent atherosclerotic events

CIRT: Methotrexate fails to prevent atherosclerotic events
November 11, 2018

Read the Perspective from Steven E. Nissen, MD, MACC


New biomarkers and therapeutic target discoveries in molecular oncology

HemOnc Today, November 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
A number of significant advances in molecular oncology have come to light in recent weeks, providing new knowledge for understanding immunotherapy response, immune…
Meeting News

Immune-related adverse events manageable with vigilance, appropriate treatment

November 8, 2018
NEW YORK — Advances in immunotherapy have transformed cancer treatment but require clinicians to be vigilant for adverse events, according to a presenter at…
Meeting News

Triple combination appears safe, effective for advanced BRAF V600-mutant melanoma

November 8, 2018
NEW YORK — The addition of spartalizumab to dabrafenib and trametinib appeared safe and effective for previously untreated patients with advanced BRAF V600-mutant…
More Headlines »

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
More »
Resource Centers